Rosacea
📧 Sign up to get email alerts when something new happens for Rosacea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA [NA]
Clinical trial update evaluating the effect of the PERFECTA V-BEAM laser on rosacea; current status is UNKNOWN and phase is not applicable.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Azelaic Acid on Demodex Counts in Rosacea [Phase 2, Phase 3]
Phase 2/Phase 3 trial updates evaluate azelaic acid for reducing Demodex counts in rosacea; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea [Phase 2]
Phase 2 trial evaluating the safety and efficacy of topical minocycline foam for papulopustular rosacea has completed.
-
FDA approval · 2017-01-18FDA Approved: RHOFADE — Original Application (EPI Health, LLC)
FDA approves Rhofade (oxymetazoline hydrochloride) from EPI Health as an original application for the treatment of persistent facial redness…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Patient-Reported Outcome Of Facial Erythema (PROOF) [Phase 3]
Phase 3 trial update for the Patient-Reported Outcome of Facial Erythema (PROOF) in rosacea with erythema; results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-16FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approved Metronidazole via an original application from Viona Pharmaceuticals Inc (ANDA206560). The approval confirms its use for anaero…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Effect of CD07805/47 Gel in Rosacea Flushing [Phase 2]
A Phase 2 trial evaluating CD07805/47 Gel for rosacea flushing has completed and posted results in October 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Open Label Pilot Study of Apremilast in Treatment of Rosacea [Phase 2]
Open-label Phase 2 pilot study of apremilast for rosacea has completed and posted results. The trial included erythematotelangiectatic and p…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea [Phase 3]
Phase 3 long-term safety and efficacy study of AGN-19920 in patients with persistent erythema associated with rosacea has completed with res…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea [Phase 2]
A Phase 2 study evaluating the safety and efficacy of PAC-14028 Cream for rosacea has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea [Phase 3]
Phase 3 clinical trial update for Oxymetazoline HCl 1.0% cream in persistent facial erythema associated with rosacea; study completed with r…
-
FDA approval · 2016-07-27FDA Approved: MIRVASO — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for MIRVASO (brimonidine tartrate) submitted by Galderma Laboratories, L.P.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea [Phase 3]
Phase 3 trial update on AGN-199201 for persistent erythema associated with rosacea reports efficacy and safety outcomes.
-
FDA approval · 2015-12-28FDA Approved: AZELAIC ACID GEL — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for AZELAIC ACID GEL from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea [NA]
This clinical trial update reports the completion of a study evaluating the safety, tolerability, and effects of Anatabloc Crème in adults w…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study [Phase 4]
Phase 4 pilot trial evaluating Finacea 15% gel and brimonidine 0.33% gel for rosacea has completed with results posted.
-
FDA approval · 2015-09-23FDA Approved: MIRVASO — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for Mirvaso (brimonidine tartrate) submitted by Galderma Laboratories, L.P., related to its labe…
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients
A clinical trial update examining Demodex density, immune response, and oxidative stress in rosacea patients; the current trial status is un…
-
FDA approval · 2015-09-21FDA Approved: DOXYCYCLINE HYCLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Doxycycline Hyclate by Hikma Pharmaceuticals USA Inc., indicating a change to the product's labe…
-
FDA approval · 2015-09-03FDA Approved: ORACEA — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for ORACEA (doxycycline) filed by Galderma Laboratories to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients [Phase 2]
Phase 2 trial evaluating topical minocycline FXFM244 for rosacea was terminated; the document does not report results.
-
FDA approval · 2015-07-29FDA Approved: FINACEA FOAM — Original Application (LEO Pharma Inc.)
FDA approved Finacea Foam, a topical azelaic acid product by LEO Pharma, under an original NDA. It is indicated for the treatment of rosacea…
-
FDA label_change · 2015-06-24FDA Approved: ORACEA — Supplemental Application (Galderma Laboratories, L.P.)
FDA supplemental approval for Oracea (doxycycline) under Galderma, indicating a labeling change related to the supplemental application.
-
FDA approval · 2015-06-14FDA Approved: METRONIDAZOLE — Supplemental Application (Encube Ethicals, Inc.)
The FDA approved a supplemental application for Metronidazole topical from Encube Ethicals, Inc., resulting in updated labeling for the prod…
-
FDA approval · 2015-04-03FDA Approved: AZELAIC ACID GEL — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for azelaic acid gel from Sandoz Inc., updating the product’s regulatory status via a supplemental N…